Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Parkinson's
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Parkinson's
    Electrode Reimplantation May Stimulate Brain in Patients With Parkinson's Disease - (DGNews)
    TopAbstracts in Parkinson's 05/07/2008 - (DGNews)
    Parkinson's Disease Patients Adhere to Rotigotine Treatment: Presented at AAN - (DGDispatch)
    Adding Entacapone Enhances Levodopa/Carbidopa Benefit in Parkinson's Patients: Presented at AAN - (DGDispatch)
    TopAbstracts in Parkinson's 04/09/2008 - (DGNews)

    News archive

     Recent webcasts/CME - Parkinson's
    • CATIE Trial Results Support Cautious Approach to Use of Antipsychotics in Older Patients
    • A Parkinson's Disease Primer
      Strategies for Enhancing Adherence in the Management of Parkinson's Disease
      Optimizing Use of a Dopamine Agonist in Parkinson's Disease
      Clinical Management of Parkinson's Disease

      Webcasts/CME archive

       Recent cases - Parkinson's
        Gliomatosis Cerebri Presenting as Rapidly Progressive Dementia and Parkinsonism in an Elderly Woman: A Case Report
        Primary Cerebral Lymphoma Presenting with Parkinsonism
        An Elderly Lady with Parkinsonism
        Diagnostic Pitfalls in Parkinson's Disease: Case Report
        Liver Transplantion in a Patient with Rapid Onset Parkinsonism-Dementia Complex Induced by Manganism Secondary to Liver Failure

        Cases archive
          




        my personal edition > parkinson's > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Alleviating Interdose Trough Disability Could Prolong Levadopa's Effects in Parkinson's

        A DGReview of :"Interactions between deep brain stimulation and levodopa in Parkinson's disease"
        Neurology

        12/07/2001
        By David Loshak


        Deep brain stimulation reduces motor fluctuations in Parkinson's disease by decreasing drug-off disability, not by altering levodopa pharmacodynamics.

        This finding suggests that reducing interdose trough disability could be an alternative way of prolonging the effects of each dose of levodopa so as to reduce motor fluctuations, report United States neurologists.

        Patients had reported that deep brain stimulation reduced levodopa-induced motor fluctuations and dyskinesia throughout the day, the researchers report. However, this had not been quantified. Nor was it known how deep brain stimulation modified the response to levodopa.

        The neurologists, at Oregon Health Sciences University, Portland, Oregon, and University of Kansas, Kansas City, US, studied 12 patients 12 to 33 months after surgery. Six of these patients were studied with bilateral globus pallidus interna electrodes and six with bilateral subthalamic nucleus electrodes.

        Patients were monitored hourly throughout two waking days with their usual oral medications -- one day with deep brain stimulation on and one day with it off.

        Both patients and nurse raters were blinded to the status of the deep brain stimulation.

        Likewise, the effects of a two-hour levodopa infusion were examined with deep brain stimulation on for one day and off for one day and, again, under double-blind conditions.

        The time course of variations in parkinsonism was evaluated by tapping speed, arising and walking speed, tremor scores and dyskinesia scores.

        It was found that deep brain stimulation raised the mean tapping speed and reduced the coefficient of variation during the waking day. This was achieved by increasing the lowest or trough tapping speed between doses of antiparkinson medications.

        Mean walking speed was modestly increased and mean tremor scores were reduced. Deep brain stimulation increased the drug-off tapping speed, but did not affect peak response or duration of response to levodopa.

        The study was not powered to detect differences between globus pallidus interna and subthalamic nucleus stimulation. The only difference that approached significance was that globus pallidus interna reduced peak dyskinesia while subthalamic nucleus tended to increase it.
        Neurology 2001;57:1835-1842. "Interactions between deep brain stimulation and levodopa in Parkinson's disease"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send